173 related articles for article (PubMed ID: 35622982)
21. Blood MALT1 deficiency is common and relates to unfavorable induction therapy response and survival profile in acute myeloid leukemia patients.
Geng H; Wang Y; Wang S
Hematology; 2022 Dec; 27(1):1176-1183. PubMed ID: 36314929
[TBL] [Abstract][Full Text] [Related]
22. Levels of Peripheral Th17 Cells and Th17-Related Cytokines in Patients with Ankylosing Spondylitis: A Meta-analysis.
Su QY; Zheng JW; Yang JY; Zhang TY; Song S; Zhao R; Di JK; Zhang SX; Wang CH; Gao HY
Adv Ther; 2022 Oct; 39(10):4423-4439. PubMed ID: 35960483
[TBL] [Abstract][Full Text] [Related]
23. Mucosa-associated lymphoid tissue lymphoma translocation protein 1 exaggerates multiple organ injury, inflammation, and immune cell imbalance by activating the NF-κB pathway in sepsis.
Wang Y; Liu Z; Zhang M; Yu B; Ai F
Front Microbiol; 2023; 14():1117285. PubMed ID: 36960276
[TBL] [Abstract][Full Text] [Related]
24. A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis.
Dumont C; Sivars U; Andreasson T; Odqvist L; Mattsson J; DeMicco A; Pardali K; Johansson G; Yrlid L; Cox RJ; Seeliger F; Larsson M; Gehrmann U; Davis AM; Vaarala O
PLoS One; 2020; 15(9):e0222548. PubMed ID: 32870913
[TBL] [Abstract][Full Text] [Related]
25. Predictive values of circulating miR-146a and miR-155 for disease activity and clinical response to TNF-α blocking therapy in patients with ankylosing spondylitis.
Liu L; Hu X
Int J Rheum Dis; 2024 Jan; 27(1):e15004. PubMed ID: 38152051
[TBL] [Abstract][Full Text] [Related]
26. Measurement of pre-treatment inflammatory cytokine levels is valuable for prediction of treatment efficacy to tumor necrosis factor inhibitor in axial spondyloarthritis patients.
Peng F; Chen F; Wen H; Bai J; Tian Y
Int J Rheum Dis; 2022 Aug; 25(8):844-850. PubMed ID: 35694730
[TBL] [Abstract][Full Text] [Related]
27. LncRNA GAS5 relates to Th17 cells and serves as a potential biomarker for sepsis inflammation, organ dysfunctions and mortality risk.
Zhang W; Chen B; Chen W
J Clin Lab Anal; 2022 May; 36(5):e24309. PubMed ID: 35325494
[TBL] [Abstract][Full Text] [Related]
28. In vivo peripheral blood proinflammatory T cells in patients with ankylosing spondylitis.
Limón-Camacho L; Vargas-Rojas MI; Vázquez-Mellado J; Casasola-Vargas J; Moctezuma JF; Burgos-Vargas R; Llorente L
J Rheumatol; 2012 Apr; 39(4):830-5. PubMed ID: 22337239
[TBL] [Abstract][Full Text] [Related]
29. Mucosa-associated lymphoid tissue lymphoma translocation protein 1 inhibition alleviates intestinal impairment induced by chronic heat stress in finisher broilers.
Zhang H; Pertiwi H; Majdeddin M; Michiels J
Poult Sci; 2024 Jan; 103(1):103252. PubMed ID: 37980762
[TBL] [Abstract][Full Text] [Related]
30. MALT-1 inhibition attenuates the inflammatory response of ankylosing spondylitis by targeting NF-κB activation.
Qin H; Wu T; Liu J; Wang G; Fan L; Wang B; Shen Y
Injury; 2021 Jun; 52(6):1287-1293. PubMed ID: 33827774
[TBL] [Abstract][Full Text] [Related]
31. Sexual Dimorphism in the Th17 Signature of Ankylosing Spondylitis.
Gracey E; Yao Y; Green B; Qaiyum Z; Baglaenko Y; Lin A; Anton A; Ayearst R; Yip P; Inman RD
Arthritis Rheumatol; 2016 Mar; 68(3):679-89. PubMed ID: 26473967
[TBL] [Abstract][Full Text] [Related]
32. Malt1 inactivation attenuates experimental colitis through the regulation of Th17 and Th1/17 cells.
Nakamura Y; Igaki K; Komoike Y; Yokoyama K; Tsuchimori N
Inflamm Res; 2019 Mar; 68(3):223-230. PubMed ID: 30564895
[TBL] [Abstract][Full Text] [Related]
33. Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-α therapy.
Xueyi L; Lina C; Zhenbiao W; Qing H; Qiang L; Zhu P
J Clin Immunol; 2013 Jan; 33(1):151-61. PubMed ID: 22926407
[TBL] [Abstract][Full Text] [Related]
34. The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells.
Brüstle A; Brenner D; Knobbe CB; Lang PA; Virtanen C; Hershenfield BM; Reardon C; Lacher SM; Ruland J; Ohashi PS; Mak TW
J Clin Invest; 2012 Dec; 122(12):4698-709. PubMed ID: 23114599
[TBL] [Abstract][Full Text] [Related]
35. Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis.
Zhang L; Li YG; Li YH; Qi L; Liu XG; Yuan CZ; Hu NW; Ma DX; Li ZF; Yang Q; Li W; Li JM
PLoS One; 2012; 7(4):e31000. PubMed ID: 22485125
[TBL] [Abstract][Full Text] [Related]
36. Oral administration effects of β-d-mannuronic acid (M2000) on Th17 and regulatory T cells in patients with ankylosing spondylitis.
Fattahi MJ; Ahmadi H; Jafarnezhad-Ansariha F; Mortazavi-Jahromi SS; Rehm BHA; Cuzzocrea S; Matsuo H; Mirshafiey A
Biomed Pharmacother; 2018 Apr; 100():495-500. PubMed ID: 29477913
[TBL] [Abstract][Full Text] [Related]
37. Management of gastric mucosa-associated lymphoid tissue lymphoma in patients with extra copies of the
Iwamuro M; Takenaka R; Nakagawa M; Moritou Y; Saito S; Hori S; Inaba T; Kawai Y; Toyokawa T; Tanaka T; Yoshino T; Okada H
World J Gastroenterol; 2017 Sep; 23(33):6155-6163. PubMed ID: 28970731
[TBL] [Abstract][Full Text] [Related]
38. Treg-promoted New Bone Formation Through Suppressing TH17 by Secreting Interleukin-10 in Ankylosing Spondylitis.
Xu F; Guanghao C; Liang Y; Jun W; Wei W; Baorong H
Spine (Phila Pa 1976); 2019 Dec; 44(23):E1349-E1355. PubMed ID: 31348182
[TBL] [Abstract][Full Text] [Related]
39. GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis.
Xia X; Cao G; Sun G; Zhu L; Tian Y; Song Y; Guo C; Wang X; Zhong J; Zhou W; Li P; Zhang H; Hao J; Li Z; Deng L; Yin Z; Gao Y
J Clin Invest; 2020 Oct; 130(10):5180-5196. PubMed ID: 32831293
[TBL] [Abstract][Full Text] [Related]
40. Blood MALT1 expression could help predict treatment outcomes in psoriasis patients, especially in those receiving biologics.
Liu Q; Zhang Y; Xu B; Jin X; Yang T; Fan L
Immun Inflamm Dis; 2024 Apr; 12(4):e1235. PubMed ID: 38578002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
